US Patent 9133183 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
Patent 9133183 was granted and assigned to Deciphera Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9133183 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
